List of bibliographic references
Number of relevant bibliographic references: 13.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 8 | Animals |
| 7 | Humans |
| 7 | Male |
| 5 | Aged |
| 5 | Aged, 80 and over |
| 4 | Dopamine (metabolism) |
| 4 | Mice |
| 4 | Parkinson Disease (metabolism) |
| 4 | Parkinson Disease (pathology) |
| 3 | Disease Models, Animal |
| 3 | Immunohistochemistry |
| 3 | Mice, Inbred C57BL |
| 3 | Neurons (pathology) |
| 3 | Parkinson Disease (physiopathology) |
| 3 | Parkinson disease |
| 3 | Rats |
| 2 | Accidental Falls |
| 2 | Apoptosis |
| 2 | Caspase 3 |
| 2 | Cell Death (physiology) |
| 2 | MPTP Poisoning (physiopathology) |
| 2 | Macaca fascicularis |
| 2 | Nerve Degeneration (pathology) |
| 2 | Neurons (enzymology) |
| 2 | Neurons (metabolism) |
| 2 | Postural Balance |
| 2 | Substantia Nigra (enzymology) |
| 1 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage) |
| 1 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects) |
| 1 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology) |
| 1 | Adult |
| 1 | Animal |
| 1 | Animal model |
| 1 | Antiparkinson agent |
| 1 | Apoptosis (drug effects) |
| 1 | Benserazide (pharmacology) |
| 1 | Benserazide (therapeutic use) |
| 1 | Blotting, Western |
| 1 | Brain (cytology) |
| 1 | Brain (enzymology) |
| 1 | Brain (immunology) |
| 1 | Brain (pathology) |
| 1 | Brain (ultrastructure) |
| 1 | Brain Stem (metabolism) |
| 1 | Brain Stem (physiopathology) |
| 1 | CD4-Positive T-Lymphocytes (cytology) |
| 1 | CD4-Positive T-Lymphocytes (immunology) |
| 1 | Calcium (metabolism) |
| 1 | Caspases (biosynthesis) |
| 1 | Caspases (metabolism) |
| 1 | Caspases (physiology) |
| 1 | Cation Transport Proteins (physiology) |
| 1 | Cells, Cultured |
| 1 | Cerebellum (metabolism) |
| 1 | Cerebellum (physiopathology) |
| 1 | Cerebral Cortex (metabolism) |
| 1 | Cerebral Cortex (physiopathology) |
| 1 | Chemotherapy |
| 1 | Cholinergic Neurons (drug effects) |
| 1 | Cholinergic Neurons (pathology) |
| 1 | Controlled Clinical Trials as Topic |
| 1 | Corpus Striatum (metabolism) |
| 1 | Corpus striatum |
| 1 | Cytoplasm |
| 1 | D1 Dopamine receptor |
| 1 | Deep Brain Stimulation |
| 1 | Diphtheria Toxin (genetics) |
| 1 | Diphtheria Toxin (toxicity) |
| 1 | Dopamine Agents (administration & dosage) |
| 1 | Dopamine Agents (adverse effects) |
| 1 | Dopamine Agents (pharmacology) |
| 1 | Dopaminergic Neurons (pathology) |
| 1 | Drug Combinations |
| 1 | Enzymatic activity |
| 1 | Enzyme Activation |
| 1 | Epinephrine (metabolism) |
| 1 | Fas Ligand Protein (genetics) |
| 1 | Fas Ligand Protein (metabolism) |
| 1 | Female |
| 1 | Gait |
| 1 | Gait (physiology) |
| 1 | Gait Disorders, Neurologic (etiology) |
| 1 | Gait Disorders, Neurologic (metabolism) |
| 1 | Gait Disorders, Neurologic (physiopathology) |
| 1 | Gait Disorders, Neurologic (therapy) |
| 1 | Homeodomain Proteins (genetics) |
| 1 | Homeodomain Proteins (metabolism) |
| 1 | Human |
| 1 | Immune System (physiology) |
| 1 | Interferon-gamma (metabolism) |
| 1 | Iron (metabolism) |
| 1 | Levodopa |
| 1 | Levodopa (pharmacology) |
| 1 | Levodopa (therapeutic use) |
| 1 | Localization |
| 1 | MPP+ |
| 1 | MPTP |
| 1 | MPTP Poisoning (complications) |
| 1 | MPTP Poisoning (drug therapy) |
| 1 | Macaca |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Etienne C. Hirsch"
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i \
-Sk "Etienne C. Hirsch" \
| HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= USA
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Etienne C. Hirsch
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
